5Wieczorek SJ, Wu AH, Christenson R, et al. A rapid B-type natriuretic peptide assary accurately diagnoses left ventricular dysfunction and heart failure : a multicenter evaluation. Am Heart J, 2002, 144:834-839.
6Chen HH, Burnett JC. Natriuretic peptides in the pathophysiology of congestive heart failure. Curr Cardiol Rep, 2000, 2:198- 205.
7Roul G, Germain P, Bareiss P. Does the 6-minute walk test predict the prognosis in patients with NYHA class Ⅱ or Ⅲ chronic heart failure? Am Heart J, 1998, 136:449-457.
8Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretie peptide in the emergency diagnosis of heart failure. N Engl J Med, 2002, 347 : 161-167.
9GROENNING B A, NILSSON J C, SONDERGAARD L, et al. Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations [J].Eur J Heart Fail, 2001,3:699-708.
10BARTON M, KIOWSKI W. The therapeutic potential of endothelin receptor antagonists in cardiovascular disease[J]. Curr Hypertens Rep, 2001,3:322- 330.
